This dashboard serves as an interactive platform for the Genomic Pioneer members. Over a period of time we can reflect back on the threads to perhaps review how the field of genomics is shaping up through our eyes. That will be interesting to see!
You do not need any sign up or give any personal information. Just pick a screen name and start typing! What are you waiting for? Get started:) Just remember this URL to come back again.

http://etherpad.com/roT866i6Ls

Some ideas to use this dashboard:

* Introducing ourselves and share interesting information about our interests, findings, anything scientific really!
* Rate interesting genomics papers and share it with the users.
* Share/Review interesting papers and stuff you came across.
* Share information and get feedback on your work
* Share and rekindle classic science which has got lost over the years
* Start a debate on a burning topic of interest!
* We will also use this platform to hold interactive sessions with key thought leaders and use it for our regular -OMICs Saturday chats!
*You can also talk live to other genomics folks online.

Any more ideas Pioneers?

cheers,
Ashwin

Dear Pioneers,

New subgroups have been created within this group in our efforts at the Gateway to create an ecosystem for theme and purpose based networking amongst key stake holders and bodies in the -OMICS area for improved collaborations and knowledge dissemination. The sub-groups are meant to identify diverse representative groups who make up this gateway. This will hopefully contribute towards better communication between members of this group.

Please feel free to join clans (subgroups) which are most applicable to you.

Industry clans http://www.linkedin.com/groups?about=&gid=2402000
Industry participants in the Genomics Pioneers Gateway- Pharma, Biotech, Services companies, Agrotech and others

Society Clans http://www.linkedin.com/groups?gid=2402019
Representative members of leading Societies and Associations in the Genomic Pioneers Gateway

Academic Clans http://www.linkedin.com/groups?gid=2402231
Representative groups from leading research centers, universities and government organizations in the Genomic Pioneers Gateway

Media Clans http://www.linkedin.com/groups?gid=2402238
Global Media representatives at the Genomic Pioneers Gateway

thanks.

best regards,
Ashwin
—-
Group Coordinator
Genomic Pioneers Gateway
An Ocimum-Gene Logic Initiative
www.genomicpioneers.com
—-

Recently, Dr.Ron Hencin, VP, BioResearch Sales, talked with Pharma Services News (BioITworld) editor John Russell about Gene Logic’s plans for the future, its increased confidence and growing reach resulting from being part of Ocimum, and the rapidly changing genomics services market and competitive landscape.

Hencin: There’s certainly a shift away from the early target discovery days when people were searching madly for what kind of mechanistic things we could uncover with expression profiling. That’s still ongoing but it’s not the only thing. I think the shift has really been made to translational medicine. The question now is how can we take what we’ve learned in clinical and preclinical or tox studies and put it into the early phase clinical trials to develop markers to identify efficacy events or adverse events and more importantly to stratify the patients moving into trials to get a better population that’s going to save costs by not having as many non-responders. The biggest area of growth is in phase one and phase two clinical trials. I see the growth in areas where genomics can be applied in much larger trials and being able to have marker-based diagnostics that you will apply to your population to monitor it during the course the larger trials for both efficacy as well as adverse events. I think that the whole genomic ADME screening market is kind of a no brainer. You have to do this because there will be more of these markers that are almost mandated by FDA as well as pharmaceutical companies

Read the complete interview at the BioITworld website